紅星美凱龍(01528.HK):阿里巴巴行使可交換債券換股權
格隆匯1月26日丨紅星美凱龍(01528.HK)發佈公吿,阿里巴巴網絡技術以每股A股人民幣8.44元的換股價格行使尚未交換可交換債券項下的換股權,以從紅星美凱龍控股獲得額外約2.176億股A股。如2023年1月20日上海證券交易所清算系統所示,阿里巴巴網絡技術自修訂以來行使尚未交換可交換債券項下的換股權,已獲得合共約2.482億股A股。
在行使可交換債券換股權後,截至該公吿日期,阿里巴巴集團控股有限公司(包括透過其於阿里巴巴網絡技術的權益)於約4.354億股股份(即公司已發行股本約9.99%)中擁有權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.